RHON-KLINIKUM Reports Strong 9M 2026 Earnings Growth

RHON-KLINIKUM AG reported strong earnings growth for the first nine months of 2026, treating 764,248 inpatients and outpatients—an 8.3% increase over the same period last year. Consolidated revenue rose to EUR 1,303.8 million (9M 2025: EUR 1,262.1 million), while EBITDA climbed to EUR 83.9 million (9M 2025: EUR 71.8 million). Consolidated profit increased to EUR 32.7 million (9M 2025: EUR 25.1 million). The results were positively impacted by a 3.25% billing surcharge on hospital services, which is accounted for through October 2026 and reported under 'other income.' The company attributed the growth to higher capacity utilization at clinics and medical care centers, particularly in the outpatient sector. With an equity ratio of 74.7%, RHON-KLINIKUM AG maintains a strong capital base that supports the optimization of inpatient and outpatient care structures.

Dr. Gunther K. WeiB, member of the Board of Management, emphasized that financial stability and medical excellence go hand in hand, crediting patient trust for the company's success. This is reflected in targeted investments in state-of-the-art medical technology. At Universitätsklinikum Marburg, a photon-counting computer tomograph was put into service, making RHON-KLINIKUM AG the only hospital group in Germany with four newest-generation units. In Frankfurt (Oder), a new hybrid operating theatre expanded treatment options and strengthened interdisciplinary structures. Dr. Stefan Stranz, also a Board member, noted that the forward-looking investment strategy ensures effective operation amid sweeping market changes, supported by the solid financial basis and collaboration within the ASKLEPIOS Group network.

For the full year 2026, RHON-KLINIKUM AG expects revenues of EUR 1.7 billion (±5%) and EBITDA between EUR 110 million and EUR 125 million. The outlook is subject to uncertainties from the Hospital Reform Adjustment Act (KHAG) and the Statutory Health Insurance Contribution Rate Stabilisation Act (GKV-BStabG), which aim to enhance quality and efficiency but will put hospitals under greater financial pressure in the short term. The company also faces higher prices, supply bottlenecks, and market volatility from global crises. The Quarterly Statement for Q3 2026 is available on the Internet. RHON-KLINIKUM AG, part of the ASKLEPIOS Group, operates five maximum- and intermediate-care facilities and employs over 19,100 people.